Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis

BACKGROUND/AIMS: Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease (NAFLD) characterized by hepatic steatosis, inflammation, hepatocellular injury, and fibrosis. We aimed to investigate the usefulness of a key biomarker, lipocalin-2 (LCN2), for the detecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Gang, Wang, Yu-Min, Ying, Miao-Miao, Chen, Sui-Dan, Li, Zong-Rui, Ma, Hong-Lei, Zheng, Ming-Hua, Wu, Jian, Ding, Chunming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046622/
https://www.ncbi.nlm.nih.gov/pubmed/33465844
http://dx.doi.org/10.3350/cmh.2020.0261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046622/
https://www.ncbi.nlm.nih.gov/pubmed/33465844
http://dx.doi.org/10.3350/cmh.2020.0261

Ejemplares similares